Insomnia Market Forecasts to 2028 – Global Analysis By Type of Diseases (Poor Quality of Sleep, Sleep Maintenance), Route of Administration (Oral Mists, Parenteral) and By Geography
According to Stratistics MRC, the Global Insomnia Market is accounted for $5124.04 million in 2021 and is expected to reach $7807.44 million by 2028 growing at a CAGR of 6.2% during the forecast period. Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as alone or conjugated with other psychiatric problems. The exact reason for the cause of insomnia is still unknown. It is most common in women and the severity may increase in conditions like postpartum, menopause and pregnancy. Insomnia disorder can be diagnosed in sleep laboratories using various diagnostic devices.
Increasing Stress in Work Place
The work conditions are presently a lot of stress for the employees which is further resulting in tension, constant thinking, and loss of sleep. Also, the market is witnessing a huge demand for OTC drugs amongst the different age groups of patients that are suffering from insomnia. Also, owing to the rising incidence of insomnia amongst people due to numerous reasons like tension and stress is likely to act as major drivers for the global growth of the market.
Lack of Clinical Training
Lack of in-depth clinical training in current medical curricula has resulted in delayed or misdiagnosed and improper treatment plans for patients. An increased understanding and screening of insomnia disorder by health care professionals could result in broader public knowledge of insomnia disorder and sleep health.
Development of New Technologies
The development of new technologies and the introduction of medical devices are anticipated to boost the market growth. The major market players are playing a significant role in the market. For instance, Eisai Co. Ltd received approval from the US Food and Drug Administration (FDA) and the firm launched its in-house discovered orexin receptor antagonist DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance in the United States.
As insomnia’s drugs can be prescribed by doctors only in special cases and under strict conditions, like morphine. These prescriptions are strictly determined by distribution and storage licenses and laws which act ac a major threat for the growth of the market.
Benzodiazepines segment is expected to be the largest during the forecast period
Benzodiazepines are a type of sedative medication. This means they slow down the body and brain's functions. They can be used to help with anxiety and insomnia (difficult getting to sleep or staying asleep) Benzodiazepines are a group of CNS depressants which induce feelings of calm (anxiolysis), drowsiness and sleep. They act by facilitating the binding of the inhibitory neurotransmitter GABA at various GABA receptors throughout the CNS.
The over-the-counter segment is expected to have the highest CAGR during the forecast period
The over-the-counter sleep aids segment is going to have lucrative growth during the forecast period attributing to the growth of this market includes easier availability, low prices, and publicity regarding the side effects of the prescription sleep aids has also steered the patients towards over-the-counter sleep aid.
Region with highest share:
The North America is projected to hold the highest market share, owing to the growing need for sleep disorder treatment in the US and Canada coupled with the growing prevalence of sleep disorders is driving the market. According to the American Academy of Sleep Medicine 2020, stress can result in adjustment insomnia, which may affect up to 20% of people in the United States each year. Poor sleeping habits in children lead to behavioural insomnia of childhood, affecting 30% of children. Prescription drugs, substance abuse, medical disorders, and mental health conditions cause insomnia, with about 3% of the population having this type of sleep issue. Specific causes include depression, drug withdrawal, obesity, and anaemia.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR. The market expansion in this province can be highly attributed to increased stress level of working population along with shift-work related sleep disorders. Asia-Pacific excluding Japan (APEJ) will also remain a remunerative region for growth of the market Governments in the province are constantly focusing on improving their healthcare system along with the provision of favourable reimbursement policies, which in turn might impact the insomnia market.
Key players in the market:
Some of the key players profiled in the Insomnia Market include Astellas, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo, ECR Pharmaceuticals, Eisai Co., Flynn Pharma, Johnson & Johnson, Meda Consumer Healthcare Inc., Merck & Co. Inc., Neurim, Pernix Therapeutics, Pfizer Inc., Purdue Pharma L.P., Sanofi Pasteur, SkyePharma, Takeda Pharmaceutical Company, Vanda Pharmaceuticals Inc. Zydus Cadila, Minerva Neurosciences Inc.
In in June 2020: Eisai Co. Ltd launched in-house discovered orexin receptor antagonist DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. All these factors are projected to increase the growth of the insomnia treatment market in the North Amer.
In July 2019: Zydus Cadila launched Ramelteon tablets, used to treat insomnia, in the US market.
In January 2021: Minerva Neurosciences Inc. and Royalty Pharma plc entered into an agreement under which Royalty Pharma will acquire Minerva’s royalty interest in seltorexant. Seltorexant, a selective orexin 2 receptor antagonist, is currently in Phase 3 development for the treatment of major depressive disorder (MDD) with insomnia symptoms.
Type of Therapy’s Covered:
• Non Pharmacological Therapy
• Pharmacological Therapy
Type of Disease’s Covered:
• Poor Quality of Sleep
• Sleep Maintenance
Route of Administrations Covered:
• Oral Mists
Drug Formulations Covered:
Drug Classes Covered:
• Senior Citizens
Distribution Channels Covered:
• Drug Stores
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
End Users Covered:
• Medical Devices
• Specialty Clinics
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 Executive Summary
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
3 Market Trend Analysis
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Insomnia Market, By Type of Therapy
5.2 Non Pharmacological Therapy
5.2.1 Cognitive Behavioral Therapy
5.2.3 Medical Devices
5.3 Pharmacological Therapy
5.3.1 Prescription Sleep Aids
5.3.2 Over-the-Counter Sleep Aids
6 Global Insomnia Market, By Type of Diseases
6.2 Poor Quality of Sleep
6.3 Sleep Maintenance
7 Global Insomnia Market, By Route of Administration
7.2 Oral Mists
8 Global Insomnia Market, By Drug Formulation
9 Global Insomnia Market, By Drug Classes
9.2.1 Orexin Antagonist
9.2.2 Melatonin Antagonist
10 Global Insomnia Market, By Application
10.4 Senior Citizens
11 Global Insomnia Market, By Distribution Channel
11.2 Drug Stores
11.3 Hospital Pharmacies
11.4 Online Pharmacies
11.5 Retail Pharmacies
12 Global Insomnia Market, By End User
12.3 Medical Devices
12.4 Specialty Clinics
13 Global Insomnia Market, By Geography
13.2 North America
13.3.6 Rest of Europe
13.4 Asia Pacific
13.4.5 New Zealand
13.4.6 South Korea
13.4.7 Rest of Asia Pacific
13.5 South America
13.5.4 Rest of South America
13.6 Middle East & Africa
13.6.1 Saudi Arabia
13.6.4 South Africa
13.6.5 Rest of Middle East & Africa
14 Key Developments
14.1 Agreements, Partnerships, Collaborations and Joint Ventures
14.2 Acquisitions & Mergers
14.3 New Product Launch
14.5 Other Key Strategies
15 Company Profiling
15.2 Biocodex S A
15.3 Consumer Healthcare Inc.
15.4 Dainippon Sumitomo
15.5 ECR Pharmaceuticals
15.6 Eisai Co.
15.7 Flynn Pharma
15.8 Johnson & Johnson
15.9 Meda Consumer Healthcare Inc.
15.10 Merck & Co. Inc.
15.12 Pernix Therapeutics
15.13 Pfizer Inc.
15.14 Purdue Pharma L.P.
15.15 Sanofi Pasteur
15.17 Takeda Pharmaceutical Company
15.18 Vanda Pharmaceuticals Inc.
15.19 Zydus Cadila
15.20 Minerva Neurosciences Inc
List of Tables
1 Global Insomnia Market Outlook, By Region (2020-2028) (US $MN)
2 Global Insomnia Market Outlook, By Type of Therapy (2020-2028) (US $MN)
3 Global Insomnia Market Outlook, By Non Pharmacological Therapy (2020-2028) (US $MN)
4 Global Insomnia Market Outlook, By Cognitive Behavioral Therapy (2020-2028) (US $MN)
5 Global Insomnia Market Outlook, By Hypnotherapy (2020-2028) (US $MN)
6 Global Insomnia Market Outlook, By Medical Devices (2020-2028) (US $MN)
7 Global Insomnia Market Outlook, By Pharmacological Therapy (2020-2028) (US $MN)
8 Global Insomnia Market Outlook, By Prescription Sleep Aids (2020-2028) (US $MN)
9 Global Insomnia Market Outlook, By Over-the-Counter Sleep Aids (2020-2028) (US $MN)
10 Global Insomnia Market Outlook, By Type of Diseases (2020-2028) (US $MN)
11 Global Insomnia Market Outlook, By Poor Quality of Sleep (2020-2028) (US $MN)
12 Global Insomnia Market Outlook, By Sleep Maintenance (2020-2028) (US $MN)
13 Global Insomnia Market Outlook, By Route of Administration (2020-2028) (US $MN)
14 Global Insomnia Market Outlook, By Oral Mists (2020-2028) (US $MN)
15 Global Insomnia Market Outlook, By Parenteral (2020-2028) (US $MN)
16 Global Insomnia Market Outlook, By Drug Formulation (2020-2028) (US $MN)
17 Global Insomnia Market Outlook, By Capsules (2020-2028) (US $MN)
18 Global Insomnia Market Outlook, By Tablet (2020-2028) (US $MN)
19 Global Insomnia Market Outlook, By Drug Classes (2020-2028) (US $MN)
20 Global Insomnia Market Outlook, By Antidepressants (2020-2028) (US $MN)
21 Global Insomnia Market Outlook, By Orexin Antagonist (2020-2028) (US $MN)
22 Global Insomnia Market Outlook, By Melatonin Antagonist (2020-2028) (US $MN)
23 Global Insomnia Market Outlook, By No benzodiazepines (2020-2028) (US $MN)
24 Global Insomnia Market Outlook, By Application (2020-2028) (US $MN)
25 Global Insomnia Market Outlook, By Female (2020-2028) (US $MN)
26 Global Insomnia Market Outlook, By Male (2020-2028) (US $MN)
27 Global Insomnia Market Outlook, By Senior Citizens (2020-2028) (US $MN)
28 Global Insomnia Market Outlook, By Distribution Channel (2020-2028) (US $MN)
29 Global Insomnia Market Outlook, By Drug Stores (2020-2028) (US $MN)
30 Global Insomnia Market Outlook, By Hospital Pharmacies (2020-2028) (US $MN)
31 Global Insomnia Market Outlook, By Online Pharmacies (2020-2028) (US $MN)
32 Global Insomnia Market Outlook, By Retail Pharmacies (2020-2028) (US $MN)
33 Global Insomnia Market Outlook, By End User (2020-2028) (US $MN)
34 Global Insomnia Market Outlook, By Homecare (2020-2028) (US $MN)
35 Global Insomnia Market Outlook, By Medical Devices (2020-2028) (US $MN)
36 Global Insomnia Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Note- Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: firstname.lastname@example.org or phone: +1-301-202-5929
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at email@example.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.